EP1082459A4 - Neue methode zur diagnose, überwachung und bestimmung des stadiums von lungenkrebs - Google Patents

Neue methode zur diagnose, überwachung und bestimmung des stadiums von lungenkrebs

Info

Publication number
EP1082459A4
EP1082459A4 EP99921894A EP99921894A EP1082459A4 EP 1082459 A4 EP1082459 A4 EP 1082459A4 EP 99921894 A EP99921894 A EP 99921894A EP 99921894 A EP99921894 A EP 99921894A EP 1082459 A4 EP1082459 A4 EP 1082459A4
Authority
EP
European Patent Office
Prior art keywords
diagnosing
monitoring
lung cancer
novel method
staging lung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99921894A
Other languages
English (en)
French (fr)
Other versions
EP1082459A1 (de
Inventor
Fei Yang
Roberto A Macina
Yongming Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Publication of EP1082459A1 publication Critical patent/EP1082459A1/de
Publication of EP1082459A4 publication Critical patent/EP1082459A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
EP99921894A 1998-05-21 1999-05-12 Neue methode zur diagnose, überwachung und bestimmung des stadiums von lungenkrebs Withdrawn EP1082459A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8621298P 1998-05-21 1998-05-21
US86212P 1998-05-21
PCT/US1999/010344 WO1999060160A1 (en) 1998-05-21 1999-05-12 A novel method of diagnosing, monitoring, and staging lung cancer

Publications (2)

Publication Number Publication Date
EP1082459A1 EP1082459A1 (de) 2001-03-14
EP1082459A4 true EP1082459A4 (de) 2002-09-25

Family

ID=22197037

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99921894A Withdrawn EP1082459A4 (de) 1998-05-21 1999-05-12 Neue methode zur diagnose, überwachung und bestimmung des stadiums von lungenkrebs

Country Status (4)

Country Link
EP (1) EP1082459A4 (de)
JP (1) JP3688585B2 (de)
CA (1) CA2328138A1 (de)
WO (1) WO1999060160A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030130182A1 (en) * 1997-11-05 2003-07-10 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030065154A1 (en) 2000-03-30 2003-04-03 Genentech, Inc. Interleukin-8 homologous polypeptides and therapeutic uses thereof
JP3524061B2 (ja) * 1998-08-04 2004-04-26 ダイアデクスアス・インコーポレーテッド 肺がんを診断し、モニターし、病期決定し、画像化し、そして処置する新規な方法
ES2317704T3 (es) * 1998-09-02 2009-04-16 Diadexus, Inc. Un nuevo metodo para el diagnostico, seguimiento, estadificacion. imagineria y tratamiento de distintos canceres.
US20020004206A1 (en) * 1999-04-09 2002-01-10 Berger Barry M. Methods of screening for disease
US20030211510A1 (en) 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2001053349A2 (en) * 2000-01-21 2001-07-26 Ludwig Institute For Cancer Research Small cell lung cancer associated antigens and uses therefor
AU2001241656A1 (en) * 2000-02-17 2001-08-27 Diadexus, Inc. Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
AU2001251084A1 (en) * 2000-03-29 2001-10-08 Diadexus, Inc. Polynucleotides and polypeptides as well as methods for diagnosing and treating lung cancer
WO2002008278A2 (en) * 2000-07-21 2002-01-31 Diadexus, Inc. Compositions and methods relating to lung specific genes
WO2002018576A2 (en) * 2000-08-28 2002-03-07 Diadexus, Inc. Compositions and methods relating to lung specific genes
EP1356038A2 (de) * 2000-10-26 2003-10-29 Diadexus, Inc. Zusammensetzungen und verfahren bezüglich lungen-spezifischen gene und proteine
WO2002068633A2 (en) * 2000-11-22 2002-09-06 Diadexus, Inc. Compositions and methods relating to lung specific genes and proteins
EP1873245A1 (de) * 2001-02-28 2008-01-02 Genentech, Inc. Interleukin-8-homologe Polypeptide und ihre therapeutische Verwendung
JP2005503145A (ja) * 2001-08-16 2005-02-03 ザ ユナイテッド ステイツ オブ アメリカ リプレゼンティッド バイ ザ シークレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ 非小細胞肺癌の分子特性
DE10254601A1 (de) * 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
WO2006013012A2 (en) * 2004-08-04 2006-02-09 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with napsin 1 (nap1)
WO2006047787A2 (en) 2004-10-27 2006-05-04 Exact Sciences Corporation Method for monitoring disease progression or recurrence
JP2008537120A (ja) 2005-04-14 2008-09-11 ザ トラスティーズ オブ ボストン ユニバーシティ 分類予測を使用した肺障害についての診断
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples
WO2007103541A2 (en) 2006-03-09 2007-09-13 The Trustees Of Boston University Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
EP2193211A4 (de) 2007-09-19 2010-12-08 Univ Boston Identfizierung neuer wege zur wirkstoffentwicklung für lungenleiden
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
EP3626308A1 (de) 2013-03-14 2020-03-25 Veracyte, Inc. Verfahren zur bewertung eines copd-status
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
EP3770274A1 (de) 2014-11-05 2021-01-27 Veracyte, Inc. Systeme und verfahren zur diagnose von idiopathischer pulmonaler fibrose auf transbronchialen biopsien mit maschinellem lernen und hochdimensionalen transkriptionsdaten
WO2018009915A1 (en) 2016-07-08 2018-01-11 Trustees Of Boston University Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039419A1 (en) * 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Colon specific genes and proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020143A1 (en) * 1996-11-05 1998-05-14 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
CA2279551A1 (en) * 1997-01-31 1998-08-06 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
US6203979B1 (en) * 1998-01-16 2001-03-20 Incyte Pharmaceuticals, Inc. Human protease molecules
CA2331386A1 (en) * 1998-06-26 2000-01-06 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039419A1 (en) * 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Colon specific genes and proteins

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE MEDLINE [online] March 1998 (1998-03-01), WANG Z ET AL: "[Expression and prognostic relation of cathepsin D in non-small cell lung cancer tissues and lymph nodes]", XP002206076, Database accession no. NLM11263354 *
See also references of WO9960160A1 *
ZHONGHUA JIE HE HE HU XI ZA ZHI = CHINESE JOURNAL OF TUBERCULOSIS AND RESPIRATORY DISEASES. CHINA MAR 1998, vol. 21, no. 3, March 1998 (1998-03-01), pages 164 - 166, ISSN: 1001-0939 *

Also Published As

Publication number Publication date
CA2328138A1 (en) 1999-11-25
JP2002515262A (ja) 2002-05-28
EP1082459A1 (de) 2001-03-14
WO1999060160A1 (en) 1999-11-25
JP3688585B2 (ja) 2005-08-31

Similar Documents

Publication Publication Date Title
EP1082459A4 (de) Neue methode zur diagnose, überwachung und bestimmung des stadiums von lungenkrebs
GB2302892B (en) Downhole gas compressor
GB2286844B (en) Wellbore monitoring apparatus
GB9502968D0 (en) Coalbed drilling
GB2345757B (en) Well logging apparatus and method
GB2347445B (en) Drilling method
GB2316424B (en) Casing segment for a wellbore and method for creating a window therein
GB2340152B (en) Multiple string completion apparatus and method
GB2303706B (en) Lung function monitoring apparatus flowheads
GB2344123B (en) Well logging method and apparatus
IL126731A0 (en) A method of detection
GB2310678B (en) Packer, packer assembly and method for a wellbore
GB2313610B (en) Method of performing a downhole operation
GB2380213B (en) Apparatus including a wellbore and wellbore casing
EP1104486A4 (de) Neues verfahren zur diagnose, zur verlaufsbeobachtung und zum abbilden von lungenkrebs
GB9701612D0 (en) Downhole production well instrumentation
EP1267934A4 (de) Neues verfahren zur diagnose, überwachung, statusbestimmung, bildmässiger darstellung und behandlung von brustkrebs
EP1082460A4 (de) Neuartiges verfahren zur diagnose, zur überwachung und verlaufsbeobachtung von prostatakrebs
GB9820919D0 (en) Diagnostic method
GB9822767D0 (en) Drilling method
EP1117833A4 (de) Ein neuartiges verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gastrointestinaler krebserkrankungen
GB9805775D0 (en) Method for forming a casing window
EP1169066A4 (de) Verfahren zur diagnostik, überwachung, stadiumfeststellung, bildgebung und behandlung von gynaekologischer krebs
EP0708307A3 (de) Messverfahren für extrem kleine Höhenschritte
EP1128848A4 (de) Verfahren zur diagnose, überwachung, bilddarstellung und behandlung von gynäkologischem krebs und prostatakrebs

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001221

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DIADEXUS, INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DIADEXUS, INC.

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12Q 1/68 A, 7G 01N 33/72 B, 7G 01N 33/574 B

A4 Supplementary search report drawn up and despatched

Effective date: 20020809

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20021029

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050504